Genesis Healthcare, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4448
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Genesis Healthcare, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Genesis Healthcare, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Genesis Healthcare, Inc. (Genesis) offers specialized healthcare services through its nursing, rehabilitation and respiratory therapy services. It focuses on elderly patients through its skilled nursing facilities, senior living communities, third-party rehabilitation therapy business and other ancillary services. It offers inpatient services through its network of skilled nursing and assisted/senior living facilities. The company also provides staffing services, and other healthcare related services. The company operates in California, Maryland, Connecticut, Massachusetts, New Hampshire, New Jersey, New Hampshire, Texas and West Virginia, the US. Genesis is headquartered in Pennsylvania, the US.

Scope

- Detailed information on Genesis Healthcare, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genesis Healthcare, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Genesis Healthcare, Inc. including a breakdown and examination of key business segments
- Intelligence on Genesis Healthcare, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genesis Healthcare, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Genesis Healthcare, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Genesis Healthcare, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Genesis Healthcare, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Genesis Healthcare, Inc.: Company Overview 9
Genesis Healthcare, Inc.: Overview and Key Facts 9
Genesis Healthcare, Inc.: Overview 9
Genesis Healthcare, Inc.: Key Facts 9
Genesis Healthcare, Inc.: Key Employees 11
Genesis Healthcare, Inc.: Key Employee Biographies 13
Genesis Healthcare, Inc.: Major Products and Services 16
Genesis Healthcare, Inc.: Company History 17
Genesis Healthcare, Inc.: Management Statement 19
Genesis Healthcare, Inc.: Locations and Subsidiaries 20
Genesis Healthcare, Inc.: Key Competitors 21
Genesis Healthcare, Inc.: Company Analysis 22
Genesis Healthcare, Inc.: Business Description 22
Genesis Healthcare, Inc.: SWOT Analysis 23
Genesis Healthcare, Inc.: SWOT Overview 23
Genesis Healthcare, Inc.: Strengths 23
Genesis Healthcare, Inc.: Weaknesses 23
Genesis Healthcare, Inc.: Opportunities 24
Genesis Healthcare, Inc.: Threats 25
Genesis Healthcare, Inc.: Corporate Financial Deals Activity 27
Genesis Healthcare, Inc.: Financial Deals Overview 27
Genesis Healthcare, Inc.: Targets and Partners 29
Genesis Healthcare, Inc.: Top Deals 2014 – 2018YTD* 30
Genesis Healthcare, Inc.: Mergers and Acquisitions 31
Genesis Healthcare, Inc.: Divestments 32
Genesis Healthcare, Inc.: Recent Developments 33
Genesis Healthcare, Inc.: News and Events Summary 33
Genesis Healthcare, Inc.: Business Expansion 34
Genesis Healthcare, Inc.: Contracts 34
Genesis Healthcare, Inc.: Financial Performance 36
Genesis Healthcare, Inc.: Regulatory and Legal Events 36
Genesis Healthcare, Inc.: Strategy and Operations 37
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: Genesis Healthcare, Inc.: Key Facts
Table 2: Genesis Healthcare, Inc.: Key Employees
Table 3: Genesis Healthcare, Inc.: Locations and Subsidiaries
Table 4: Genesis Healthcare, Inc.: Key Competitors
Table 5: Genesis Healthcare, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Genesis Healthcare, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Genesis Healthcare, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Genesis Healthcare, Inc.: Targets and Partners
Table 9: Genesis Healthcare, Inc.: Top Deals 2014 - 2018YTD*
Table 10: Genesis Healthcare, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Genesis Healthcare, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 12: Genesis Healthcare, Inc.: Divestments by Geography (2014 - YTD*2018)
Table 13: Genesis Healthcare, Inc.: News and Events Summary
Table 14: Genesis Healthcare, Inc.: Business Expansion
Table 15: Genesis Healthcare, Inc.: Contracts
Table 16: Genesis Healthcare, Inc.: Financial Performance
Table 17: Genesis Healthcare, Inc.: Regulatory and Legal Events
Table 18: Genesis Healthcare, Inc.: Strategy and Operations

List of Figures
Figure 1: Genesis Healthcare, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Genesis Healthcare, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Genesis Healthcare, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Genesis Healthcare, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Genesis Healthcare, Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Genesis Healthcare, Inc.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Genesis Healthcare, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Guangdong Carpoly Chemical Group Co Ltd:企業の戦略的SWOT分析
    Guangdong Carpoly Chemical Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Syncardia Systems LLC:企業の戦略的SWOT分析
    Syncardia Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • 01 Communique (ONE):企業の財務・戦略的SWOT分析
    Summary 01 Communique (Communique) is a technology company that develops and delivers integrated communication software and services. The company's products include I'm InTouch meeting, I'm InTouch, I'm OnCall and Communicate!. Its I'm InTouch provides a secure and easy to use PC remote access softw …
  • Qaf Limited:企業の戦略・SWOT・財務分析
    Qaf Limited - Strategy, SWOT and Corporate Finance Report Summary Qaf Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • BP Plc:企業のM&A・事業提携・投資動向
    BP Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BP Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報
    Summary Ovid Therapeutics Inc (Ovid Therapeutics) is a bio-pharmaceutical company which identifies, discovers, and develops medicines for neurological disorders. The company’s pipeline products are indicated for diseases such as Angelman Syndrome and Fragile X Syndrome. It develops, assess, commerci …
  • TransMontaigne Partners LP (TLP):企業の財務・戦略的SWOT分析
    Summary TransMontaigne Partners LP (TLP), a subsidiary of TransMontaigne GP LLC is an energy infrastructure service provider that offers integrated terminaling, transportation, and storage services. The company distributes and transports crude oil, chemicals, petroleum products, fertilizers, and oth …
  • Standardkessel Baumgarte Holding GmbH:企業の戦略的SWOT分析
    Standardkessel Baumgarte Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pearl Global Industries Limited:企業の戦略・SWOT・財務情報
    Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Eurazeo SA (RF):企業の財務・戦略的SWOT分析
    Summary Eurazeo SA (Eurazeo) is an investment service provider that offers investment services. The company offers detection and acquisition, retention and divestment and enhancement programs. It provides retention services such as CSR reporting, deployment of CSR essentials, drafting, monitoring an …
  • Central Japan Railway Company:企業の戦略・SWOT・財務情報
    Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Goals Soccer Centres plc (GOAL):企業の財務・戦略的SWOT分析
    Goals Soccer Centres plc (GOAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Husky Energy Inc:企業の戦略・SWOT・財務情報
    Husky Energy Inc - Strategy, SWOT and Corporate Finance Report Summary Husky Energy Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Euticals SpA-製薬・医療分野:企業M&A・提携分析
    Summary Euticals SpA (Euticals) is a chemical company that develops and supplies active pharmaceutical ingredients, fine chemicals and contract manufacturing. The company possess technologies and capabilities in the domains of fermentation and enzymatic chemistry; boronic acids, biaryls, grignards a …
  • Open Monoclonal Technology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Open Monoclonal Technology Inc (OMT), a subsidiary of Ligand Pharmaceuticals Inc, is a biotechnology company that discovers and develops human monoclonal antibody platform based on transgenic rats. The company provides products such as omnirat, omnimouse and omniflic. Its omnirat is an antib …
  • Midland Power Cooperative:発電所・企業SWOT分析
    Midland Power Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • American National Insurance Co:戦略・SWOT・企業財務分析
    American National Insurance Co - Strategy, SWOT and Corporate Finance Report Summary American National Insurance Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆